heart iconheart icon
Share

Payment Breakdown

On June 30, 2017, the Centers for Medicare and Medicaid Services (CMS) published industry-wide Open Payments data for the period between January 1, 2016 – December 31, 2016 on the Open Payments website (http://go.cms.gov/openpayments).

In addition to information posted on the CMS website, and in an effort to provide the most accurate and timely information, Johnson & Johnson has voluntarily posted the aggregated data for our companies covered by Open Payments, as submitted on March 31, 2017. Please note, due to the CMS data review process, there may be differences between the aggregated totals for data posted here and aggregated totals derived from currently available data on the CMS website.
expand
From These Collaborations Come Great Innovations Such As:
expand
Janssen has launched 12 new molecular entities since 2011.

expand

Obesity is rapidly becoming a global epidemic. Obese patients are also impacted by known co-morbidities like increased cardiovascular disease, osteoarthritis and diabetes. Company funded pre-clinical and clinical research has impacted the medical community’s understanding of these co-morbidities. Patients and the medical community have benefited from evidence-based treatment options.


expand

The ATTUNE® Knee Replacement System, which was developed after six years of comprehensive research and testing with academic institutions and collaboration with 35 orthopaedic surgeons from around the world. This revolutionary device is designed to help improve stability and motion for recipients.

expand

The advancement of minimally invasive surgery into more specialized and serious conditions, such as cancer and obesity. As pioneer in the field of minimally invasive surgery, our collaborations with the surgical community changed the way many common surgeries are performed. Through our continued partnership, the field has progressed in recent years. Our goal is to develop devices that can assist with the removal of cancerous tumors that are more precise and efficient such as our innovative energy and endocutter devices developed in collaboration with surgeons who use them to treat their patients.

expand

Reproducible cardiac ablation procedures that improve patient outcomes. In over 20 Training Expertise Centers around the U.S., skilled physicians who have mastered the use of our ablation tools, like the THERMOCOOL SMARTTOUCH® Contact Force Sensing Catheter and the CARTO® 3 3-D mapping system, share best practices with their peers regarding procedural techniques, patient management and follow-up.